<DOC>
	<DOCNO>NCT00293176</DOCNO>
	<brief_summary>To investigate efficacy safety donepezil individual mild cognitive impairment measure cognition , global function behavior .</brief_summary>
	<brief_title>The Evaluation Efficacy Safety Donepezil Hydrochloride Subjects With Mild Cognitive Impairment ( MCI )</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Amnesia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Memory complaint Mini Mental Status Exam ( MMSE ) score 2428 inclusive General cognition function performance sufficiently preserve diagnosis Alzheimer 's disease ( AD ) make Generally healthy ambulatory Sufficiently fluent English Diagnosis probable possible AD Neurological disorder History malignant cancer Previously take donepezil acetylcholinesterase ( ChE ) inhibitor 1 month past 3 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Cognitive impairment</keyword>
	<keyword>Memory Loss</keyword>
</DOC>